Reduced-intensity conditioning for HLA-haploidentical hematopoietic cell transplantation was augmented with same-donor memory-like natural killer (NK) cells on day +7 and 3 weeks of N-803 to treat patients with relapsed/refractory AML in a clinical trial.
[Science Translational Medicine]
6445212
BBBBBBBB
items
1
apa
0
default
asc
1
172356
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/